Tag Archives: AML

July, 2017

June, 2017

May, 2017

April, 2017

March, 2017

February, 2017

  • 24 February

    Cyclacel’s Acute Myeloid Leukemia Drug Fails Late-Stage Study

    BERKELEY HEIGHTS, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported top-line results from the pivotal Phase …